KVX-053, a PTP4A3 inhibitor, as antidote against CEES-induced Acute Lung Injury
R. Colunga Biancatelli (Norfolk, United States), P. Solopov (Norfolk, United States), J. Lazo (Charlottesville, United States), E. Sharlow (Charlottesville, United States), B. Ruedlinger (Norfolk, United States), S. Beebe (Norfolk, United States), J. Catravas (Norfolk, United States)
Source: International Congress 2022 – Identifying therapeutic targets and novel drug strategies in pulmonary diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Colunga Biancatelli (Norfolk, United States), P. Solopov (Norfolk, United States), J. Lazo (Charlottesville, United States), E. Sharlow (Charlottesville, United States), B. Ruedlinger (Norfolk, United States), S. Beebe (Norfolk, United States), J. Catravas (Norfolk, United States). KVX-053, a PTP4A3 inhibitor, as antidote against CEES-induced Acute Lung Injury. 2842
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|